Mary J. Grendell
Conseiller Juridique Général chez PROTARA THERAPEUTICS, INC.
Profil
Mary J.
Grendell is currently working as Secretary & General Counsel at Protara Therapeutics, Inc. She previously worked as Senior Counsel-Transactions Group at Amgen, Inc., Senior Counsel- Global Business Development at Mylan, Inc., and Secretary, Vice President & Deputy General Counsel at Intercept Pharmaceuticals, Inc. Ms. Grendell completed her undergraduate degree at Yale University and her graduate degree at The University of Pennsylvania Law School.
Postes actifs de Mary J. Grendell
Sociétés | Poste | Début |
---|---|---|
PROTARA THERAPEUTICS, INC. | Conseiller Juridique Général | - |
Anciens postes connus de Mary J. Grendell
Sociétés | Poste | Fin |
---|---|---|
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | - |
AMGEN INC. | Corporate Officer/Principal | - |
INTERCEPT PHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Formation de Mary J. Grendell
The University of Pennsylvania Law School | Graduate Degree |
Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
PROTARA THERAPEUTICS, INC. | Health Technology |
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
AMGEN INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |